학술논문

Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies JACC State-of-the-Art Review
Document Type
article
Source
Journal of the American College of Cardiology. 76(10)
Subject
Biomedical and Clinical Sciences
Cardiovascular Medicine and Haematology
Heart Disease
Biomedical Imaging
Cardiovascular
Atherosclerosis
Heart Disease - Coronary Heart Disease
4.1 Discovery and preclinical testing of markers and technologies
4.2 Evaluation of markers and technologies
Detection
screening and diagnosis
Good Health and Well Being
Biomedical Technology
Chest Pain
Computed Tomography Angiography
Coronary Angiography
Coronary Artery Disease
Humans
Review Literature as Topic
Risk Assessment
Vascular Calcification
atherosclerosis
coronary artery disease
coronary computed tomography angiography
Cardiorespiratory Medicine and Haematology
Public Health and Health Services
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Language
Abstract
Evaluation of coronary artery disease (CAD) using coronary computed tomography angiography (CCTA) has seen a paradigm shift in the last decade. Evidence increasingly supports the clinical utility of CCTA across various stages of CAD, from the detection of early subclinical disease to the assessment of acute chest pain. Additionally, CCTA can be used to noninvasively quantify plaque burden and identify high-risk plaque, aiding in diagnosis, prognosis, and treatment. This is especially important in the evaluation of CAD in immune-driven conditions with increased cardiovascular disease prevalence. Emerging applications of CCTA based on hemodynamic indices and plaque characterization may provide personalized risk assessment, affect disease detection, and further guide therapy. This review provides an update on the evidence, clinical applications, and emerging technologies surrounding CCTA as highlighted at the 2019 National Heart, Lung and Blood Institute CCTA Summit.